Fall Prevention Research
The report “To Err is Human,” published in 1999, estimated adverse events in hospitals to cause 44–98,000 deaths within the USA per annum . The report draws attention to a crucial
health care-related concern and has resulted during a significant increase in
patient safety efforts, like system-based interventions, practical clinical initiatives, and research. In 2004, the WHO established the network World Alliance for Patient Safety, which aims to coordinate, disseminate, and accelerate improvements in
patient safety worldwide. Systems for reporting adverse events are in use internationally for quality assurance and patient safety. Worldwide, falls are one among the foremost commonly reported adverse events in hospitals with prevalence rates within the order of 10 per 1,000 patient days or 5%–15% of the patients and are related to both minor and major injuries Preventive measures are crazy conflicting results. Overall,
fall prevention exercise interventions have shown no effect, while vitamin D supplement has reduced the speed of falls but not the danger of falls in elderly in
nursing homes.Multifactorial interventions in hospitals have shown a discount within the rate of falls and an inconclusive trend for the danger of falling consistent with a Cochrane review. In large,
fall prevention measures in hospitals are disappointing.Norway has since 1994 had a national system for reporting adverse events in hospitals. The database has been wont to plan and implement prevention activities associated with frequent and high adverse events. Eleven percent of all reports from the specialized
health services were incidents associated with falls.
High Impact List of Articles
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
PEARL translational network: an infrastructure for person-centricity and improved clinical outcomes
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley Grill, Don Vena, Louis Terracio & Van P Thompson
Research Update: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Novel treatment strategies for patients with nonalcoholic fatty liver disease
Brian Lam,Zobair M Younossi
Therapeutic Prospective: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Tyrosine kinase inhibitors in differentiated thyroid arcinoma: a review of the clinical evidence
Hendrieke C Hoftijzer, Ellen Kapiteijn2, Tatiana, Schneider, Guido C Hovens, Hans Morreau, Hans Gelderblom, Johannes WA Smit
Review Article: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
-
Diabetes vaccines: review of the clinical evidence
Johnny Ludvigsson
Review Article: Clinical Investigation
Relevant Topics in Clinical